These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 420718)
1. Unusual electromyographic findings in a patient with polymyalgia rheumatica. Gross MD; Borkin MH; Rupp S Arthritis Rheum; 1979 Mar; 22(3):277-80. PubMed ID: 420718 [TBL] [Abstract][Full Text] [Related]
2. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica. González-Gay MA; García-Porrúa C; Vázquez-Caruncho M J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456 [TBL] [Abstract][Full Text] [Related]
4. Recognition of giant cell arteritis in patients with polymyalgia rheumatica who have a stroke: a cautionary tale. Gutteridge DH; Mastaglia FL Intern Med J; 2017 Oct; 47(10):1199-1201. PubMed ID: 28994265 [TBL] [Abstract][Full Text] [Related]
5. Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica. Rodriguez-Valverde V; Sarabia JM; González-Gay MA; Figueroa M; Armona J; Blanco R; Fernández-Sueiro JL; Martínez-Taboada VM Am J Med; 1997 Apr; 102(4):331-6. PubMed ID: 9217613 [TBL] [Abstract][Full Text] [Related]
6. An unusual presentation of polymyalgia rheumatica with severe muscle weakness. Radhamanohar M Br J Clin Pract; 1992; 46(3):213-4. PubMed ID: 1286029 [TBL] [Abstract][Full Text] [Related]
7. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Roche NE; Fulbright JW; Wagner AD; Hunder GG; Goronzy JJ; Weyand CM Arthritis Rheum; 1993 Sep; 36(9):1286-94. PubMed ID: 8216422 [TBL] [Abstract][Full Text] [Related]
8. Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumatica. Salvarani C; Gabriel SE; Gertz MA; Bjornsson J; Li CY; Hunder GG Arthritis Rheum; 1994 Nov; 37(11):1621-6. PubMed ID: 7980674 [TBL] [Abstract][Full Text] [Related]
9. Development of giant cell (temporal) arteritis in a patient 'adequately' treated for polymyalgia rheumatica. Rynes RI; Mika P; Bartholomew LE Ann Rheum Dis; 1977 Feb; 36(1):88-90. PubMed ID: 843118 [TBL] [Abstract][Full Text] [Related]
10. [Risk factors for the development of vision disorders in polymyalgia rheumatica with giant cell arteritis]. Bohle W; Stettin A; Jipp P Dtsch Med Wochenschr; 2000 Jun; 125(22):681-5. PubMed ID: 10874894 [TBL] [Abstract][Full Text] [Related]
11. [Polymyalgia rheumatica and giant cell arteritis]. Jipp P; Fehring K Dtsch Med Wochenschr; 1984 Oct; 109(43):1635-8. PubMed ID: 6489177 [TBL] [Abstract][Full Text] [Related]
12. Antimitochondrial Antibodies and Primary Biliary Cholangitis in Patients with Polymyalgia Rheumatica/Giant Cell Arteritis. Manzo C; Maslinska M; Castagna A; Hysa E; Merante A; Milchert M; Gravina T; Sargin B; Natale M; Ruberto C; Ruotolo G Medicina (Kaunas); 2021 Apr; 57(4):. PubMed ID: 33917502 [No Abstract] [Full Text] [Related]